Philips

Cell Signaling Technologies, based in Beverly, MA, is recognized globally for its extensive range of high-quality antibodies and related research products, serving the life sciences community for over 25 years. The company's product offerings include primary and secondary antibodies, ELISA kits, cellular assay kits, and an array of reagents and comprehensive solutions tailored for various applications including cancer research, immunology, and neuroscience. With a commitment to reliability and validation, Cell Signaling Technologies provides leading-edge solutions for research through robust assay platforms and continuous supply of essential products. Their dedication to environmental and social responsibility further underscores their role as a trusted partner in advancing scientific discovery. Generated from the website

Akamai Technologies is a worldwide leader in distributed computing solutions and services. It provides services for accelerating content and business processes online. The company developed one of the world's largest and widely used on-demand distributed computing platforms with more than 14,000 servers in 1,100 networks throughout 65 countries. Akamai has more than 1,900 customers worldwide. Akamai Technologies has headquarters in Cambridge, Mass., and operations worldwide.